Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer
Open Access
- 8 June 2010
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 103 (1), 101-111
- https://doi.org/10.1038/sj.bjc.6605720
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell CarcinomaClinical Cancer Research, 2009
- Diagnostic and Prognostic Molecular Markers for Renal Cell Carcinoma: A Critical Appraisal of the Current State of Research and Clinical ApplicabilityEuropean Urology, 2009
- Integrated multi-level quality control for proteomic profiling studies using mass spectrometryBMC Bioinformatics, 2008
- Proteomic Contributions to Personalized Cancer CareMolecular & Cellular Proteomics, 2008
- Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populationsLaboratory Investigation, 2007
- Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitationscclm, 2007
- Clear Cell Renal Cell Carcinoma: Gene Expression Analyses Identify a Potential Signature for Tumor AggressivenessClinical Cancer Research, 2005
- Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patientsLaboratory Investigation, 2004
- Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD InitiativeClinical Chemistry, 2003
- The acute phase protein response in patients receiving subcutaneous IL-6Clinical and Experimental Immunology, 1995